Evidence map›Paper›PMID 40119249›Full record

ArticleMolecular neurobiology2025

Glutathione-protected Au

Yihui Zheng, Xiaoli Feng, Xinying Hu, Tingyu Zhu, Jialuo Ding, Niping Mao, Hejie Xu, Jia Lou, Junhui Yuan, Xingyun Wang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yihui Zheng *Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Xiaoli Feng *Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Xinying HuResearch Center of Basic Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Tingyu ZhuDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Jialuo DingResearch Center of Basic Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Niping MaoDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Hejie XuResearch Center of Basic Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.
Jia LouDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Junhui YuanWenling Maternal and Child Health Care Hospital, Wenling City, China.
Xingyun WangHongqiao International Institute of Medicine, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zhenlang LinDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China.
Zhenkun LinResearch Center of Basic Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China. zklin@wmu.edu.cn.
Jianghu ZhuDepartment of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, China. zhujianghu@wmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxic-ischemic brain damage (HIBD) arises from perinatal hypoxia, a leading cause of neonatal mortality during the perinatal period, as well as subsequent disabilities beyond the neonatal stage. While there is currently no unified and comprehensive treatment approach for hypoxic-ischemic encephalopathy (HIE), hypothermia therapy represents the only recognized clinical intervention. Nevertheless, the efficacy of hypothermia therapy remains limited. Recently, atomically precise metal nanoclusters (NCs), an emerging class of nanomaterials, has displayed promising potential in biomedical field. This study aimed to assess whether glutathione-protected Au

Indexed as

GlutathioneGoldHypoxia-Ischemia, BrainMetal NanoparticlesSignal TransductionSirtuin 3Superoxide DismutaseAnimalsAnimals, NewbornApoptosisGlucoseMaleNeuronsNeuroprotective AgentsOxidative StressRatsGlucoseGlutathioneGoldNeuroprotective AgentsSIRT3 protein, ratSirtuin 3SirtuinsSuperoxide DismutaseSuperoxide Dismutase 2Gold nanoclustersHypoxic-ischemic brain injuryNeuroprotectionOxidative stressSirt3/SOD2

Identifiers

PMID40119249

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.